Phosphorylated-Survivin at Ser81 Induced Protein Kinase A (PKA): A Back Loop

Ferry Sandra, Roya Khosravi-Far


BACKGROUND: Survivin, a bifunctional protein, acts as suppressor of apoptosis and has an essential role in mitosis. Survivin is physically phosphorylated on Thr34, and other important sites such as Thr117, Ser20, Thr48 and Ser81. Our previous report has shown that Ser81 of survivin plays role in cytoprotection. In order to investigate the underlying mechanism, all motifs with medium stringency were scanned. We found that site of survivin at Ser81 was correlated to PKA, which is well reported to many cell signal machineries, including cell survival. Therefore, we focused our current investigation in finding possible correlation and interaction between survivin’s Ser81 site and PKA.

METHODS: Wild-type survivin (Survivin), antisense survivin (Survivin-AS), mutated-survivin and mutated-survivin Ser81Ala (Survivin-S81A) were constructed. Each retroviral product was produced. Some cell lysates were prepared and immunoprecipitated. For analysis, we performed immunoblotting and PKA’s activity assays.

RESULTS: In our current results, phosphorylated-PKA was correlated with survivin. Infection of survivin could lead to acceleration of PKA’s activity in a viral particle dependent manner. This positive back loop induction by survivin was shown to be correlated to Ser81 site, since survivin-mediated PKA activity was not resulted by mutated form of survivin at Ser81 to nonphosphorylatable Ala (S81A).

CONCLUSIONS: Our results suggested a possible back loop of survivin to activate PKA, and Ser81 could be an important site to mediate the survivin-PKA back loop signaling. Survivin-induced activation of PKA might be related to cytoprotection.

KEYWORDS: survivin, S81A, L929, PKA

Full Text:



Colnaghi R, Connel CM, Barret RMA, Wheatley SP. Separating the anti-apoptotic and mitotic roles of survivin. J Biol Chem. 2006; 281: 33450-6, CrossRef.

Aspe JR, Wall NR. Survivin-T34A: molecular mechanism and therapeutic potential. Onco Targets Ther. 2010; 3: 247-54, CrossRef.

Altieri DC. New wirings in the surviving networks. Oncogene. 2008; 27: 6276-84, CrossRef.

Altieri DC. Survivin and IAP protein in cell-death mechanisms. Biochem J. 2010; 430: 199-205, CrossRef.

Dohi T, Xia F, Altieri DC. Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Mol Cell. 2007; 27: 17-28, CrossRef.

Barrett RMA, Colnaghi R, Wheatley SP. Threonine 48 in the BIR domain of survivin is critical to its mitotic and anti-apoptotic activities and can be phosphorylated by CK2 in vitro. Cell Cycle. 2011; 10: 538-48, CrossRef.

Sandra F, Khosravi-Far R. Survivin S81A Enhanced TRAIL’s activity in inducing apoptosis. Indones Biomed J. 2010; 2: 113-7, CrossRef.

Deming PB, Campbell SL, Baldor LC, Howe AK. Protein kinase A regulates 3-phosphatidylinositide dynamics during platelet-derived growth factor-induced membrane ruffling and chemotaxis. J Biol Chem. 2008; 283: 35199-211, CrossRef.

Taylor SS, Yang J, Wu J, Haste NM, Radzio-Andzelm E, Anand G. PKA: a portrait of protein kinase dynamics. Biochim Biophys Acta. 2004; 1697: 259-69, CrossRef.

Tasken K, Aandahl EM. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev. 2004; 84: 137-67, CrossRef.

Kirschner LS, Yin Z, Jones GN, Mahoney E. Mouse models of altered protein kinase A signaling. Endocr Relat Cancer. 2009; 16: 773-93, CrossRef.

Taylor SS, Kim S, Cheng CY, Brown SH, Wu J, Kannan N. Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design. Biochim Biophys Acta. 2008; 1784: 16-26, CrossRef.

deBlaquiere J, Walker F, Michelangeli VF, Fabri L, Burgess AW. Platelet-derived growth factor stimulates the release of protein kinase A from the cell membrane. J Biol Chem. 1994; 269: 4812-8, PMID.

Harada H, Becknell B, Wilm M, Mann M, Huang LJ, Taylor SS, et al. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol Cell. 1999; 3: 413-22, CrossRef.

Gurumurthy S, Goswami A, Vasudevan KM, Rangnekar VM. Phosphorylation of Par-4 by protein kinase A is critical for apoptosis. Mol Cell Biol. 2005; 25: 1146-61, CrossRef.

LaCasse EC, Baird S, Komeluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 1998; 17: 3247-59, CrossRef.

Ye K. Phosphorylation of merlin regulates its stability and tumor suppressive activity. Cell Adh Migr. 2007; 1: 196-8, CrossRef.

Jurek A, Amagasaki K, Gembarska A, Heldin CH, Lennartsson J. Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation. J Biol Chem 2009; 284: 4626-34, CrossRef.

Lizcano JM, Morrice N, Cohen P. Regulation of BAD by cAMPdependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem J. 2000; 349: 547-57, CrossRef.

Gao N, Hibi Y, Cueno M, Asamitsu K, Okamoto T. A-kinase-interacting protein 1 (AKIP1) acts as a molecular determinant of PKA in NF-kappaB signaling. J Biol Chem. 2010; 285: 28097-104, CrossRef.


Indexed by:






The Prodia Education and Research Institute